Hepatitis B in liver transplant recipients as a special model of antiviral drug development

Methods Mol Med. 2004:96:319-41. doi: 10.1385/1-59259-670-3:319.
No abstract available

MeSH terms

  • Administration, Oral
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use*
  • Hepatitis B / drug therapy*
  • Hepatitis B Vaccines / administration & dosage
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Interferons / therapeutic use
  • Liver Transplantation*
  • Tissue Donors

Substances

  • Antiviral Agents
  • Hepatitis B Vaccines
  • Immunosuppressive Agents
  • Interferons